Natixis’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.65M Sell
17,076
-22,703
-57% -$7.73M 0.02% 407
2025
Q4
$15.8M Buy
+39,779
New +$17.6M 0.06% 250
2024
Q3
Sell
-291
Closed -$70.7K 953
2024
Q2
$70.7K Sell
291
-391
-57% -$61.7K ﹤0.01% 765
2024
Q1
$102K Buy
+682
New +$114K ﹤0.01% 773
2022
Q4
Sell
-226,034
Closed -$45.3M 1080
2022
Q3
$45.3M Buy
226,034
+218,295
+2,821% +$41.6M 0.21% 80
2022
Q2
$1.13M Buy
7,739
+5,373
+227% +$762K ﹤0.01% 798
2022
Q1
$386K Sell
2,366
-101,696
-98% -$15.5M ﹤0.01% 1022
2021
Q4
$17.6M Buy
104,062
+1,546
+2% +$287K 0.06% 271
2021
Q3
$19.4M Buy
102,516
+94,044
+1,110% +$17.6M 0.07% 242
2021
Q2
$1.44M Buy
8,472
+1,961
+30% +$287K 0.01% 570
2021
Q1
$919K Buy
6,511
+4,525
+228% +$681K ﹤0.01% 845
2020
Q4
$258K Sell
1,986
-616
-24% -$82.3K ﹤0.01% 973
2020
Q3
$379K Buy
+2,602
New +$370K ﹤0.01% 633

Other funds holding ALNY